Towards an Open-Source Platform to Harmonize and Share Research Results from COVID-19 Interventional and Observational Studies.

As the SARS-CoV-2 virus continues to remain a universal threat on a global scale, a large number of COVID-19 clinical trials and observational studies are being conducted and published. Currently, 9,202 COVID-19 clinical trials have been registered on ClinicalTrials.gov and 293,187 COVID-19 articles were indexed in PubMed. To fully capitalize on the voluminous number of publications reporting COVID-19 interventional and observational studies, their results should be freely accessible via an open-source harmonized shared resource. We introduced ReMeDy (https://remedy.mssm.edu/), an intelligent integrative informatics platform aimed to harmonize and cross-link diverse COVID-19 trial outcomes and observational data. We tested the potential of the platform by uploading 52 COVID-19 clinical trials and 48 COVID-19 observational retrospective studies. ReMeDy was validated based on its capability to store and organize diverse data. The next steps include developing a crowdsourcing functionality coupled with automated outcome extraction using natural language processing.